Two Sigma Investments
DNTH icon

Two Sigma Investments’s Dianthus Therapeutics DNTH Stock Holding History

Two Sigma Investments’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,400
Closed -$1.99M – 4657
2025
Q4 		$1.99M Buy
+48,400
New +$1.88M ﹤0.01% 2433
2025
Q1 		– Sell
-10,601
Closed -$231K – 3267
2024
Q4 		$231K Sell
10,601
-588
-5% -$15.1K ﹤0.01% 2824
2024
Q3 		$306K Buy
11,189
+689
+7% +$19.2K ﹤0.01% 2661
2024
Q2 		$272K Sell
10,500
-27,471
-72% -$660K ﹤0.01% 2639
2024
Q1 		$1.14M Buy
+37,971
New +$825K ﹤0.01% 1877
2023
Q3 		– Sell
-7,517
Closed -$91.2K – 3006
2023
Q2 		$91.2K Buy
7,517
+1,806
+32% +$20.5K ﹤0.01% 2765
2023
Q1 		$72.6K Sell
5,711
-5,922
-51% -$65.6K ﹤0.01% 2709
2022
Q4 		$73.5K Buy
11,633
+3,442
+42% +$60.9K ﹤0.01% 2547
2022
Q3 		$185K Sell
8,191
-4,407
-35% -$121K ﹤0.01% 2127
2022
Q2 		$242K Buy
12,598
+2,734
+28% +$67.6K ﹤0.01% 2100
2022
Q1 		$458K Sell
9,864
-1
-0% -$55 ﹤0.01% 2064
2021
Q4 		$699K Buy
9,865
+967
+11% +$97.2K ﹤0.01% 2903
2021
Q3 		$1.04M Sell
8,898
-1,793
-17% -$209K ﹤0.01% 2588
2021
Q2 		$1.67M Buy
10,691
+798
+8% +$147K ﹤0.01% 2022
2021
Q1 		$1.87M Sell
9,893
-2,512
-20% -$423K ﹤0.01% 1761
2020
Q4 		$1.56M Buy
12,405
+707
+6% +$80.2K ﹤0.01% 1666
2020
Q3 		$1.27M Buy
11,698
+10,973
+1,514% +$1.3M ﹤0.01% 1594
2020
Q2 		$87K Sell
725
-346
-32% -$48.7K ﹤0.01% 2800
2020
Q1 		$108K Buy
+1,071
New +$198K ﹤0.01% 2829
2019
Q1 		– Sell
-1,145
Closed -$104K – 3119
2018
Q4 		$104K Buy
+1,145
New +$156K ﹤0.01% 2806

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments's DNTH Position: Q1 2026 in Review

Two Sigma Investments sold out of Dianthus Therapeutics (DNTH) in Q1 2026, closing a stake of 48,400 shares — an estimated $1.99M sold.

Two Sigma Investments first reported a position in DNTH in Q4 2018 and held it in 20 quarters. The position peaked at $1.99M in Q4 2025. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Two Sigma Investments reported no remaining Dianthus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 48,400 Dianthus Therapeutics shares in Q1 2026, an estimated $1.99M.
  • Two Sigma Investments first reported a position in Dianthus Therapeutics in Q4 2018 and held it in 20 quarters.
  • Two Sigma Investments's Dianthus Therapeutics position peaked at $1.99M in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.